- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0177242

Enrish Pharmaceutical Private Limited
About Enrish Pharmaceutical Private Limited
Data last updated:
Enrish Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC280805. Its GSTIN is 27AAECE2708E1ZZ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sushant Sudhir Bala and Vijaykumar Shankarrao Moon.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No A 102 Gurudarshan Apartme Shreya Building Nandivali Dombivali East Kalyan Tahne, Thane, Maharashtra, India – 421201.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.03 Cr, a growth of 70% compared to the previous year. For the same year it recorded a net profit of ₹1.88 Lakh (net margin 1.8%) and EBITDA of ₹2.87 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 121% over three years and 44% over five years.
As per MCA filings, the company has open charges of ₹8 Lakh on record.
Enrish Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0177242). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Enrish Pharmaceutical
Contact details
Enrish Pharmaceutical Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No A 102 Gurudarshan Apartme Shreya Building Nandivali Dombivali East Kalyan Tahne, Thane, Maharashtra, India – 421201
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Enrish Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Enrish Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Enrish Pharmaceutical Private Limited, buy the company report.
Financials of Enrish Pharmaceutical Private Limited
FY 2024 filings availableEnrish Pharmaceutical Private Limited reported revenue of ₹1.03 Cr (up 70% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 70% growth in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Enrish Pharmaceutical Private Limited, buy the company report.
Board of directors of Enrish Pharmaceutical Private Limited
Enrish Pharmaceutical has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushant Sudhir Bala Also directs: Enrish Natural Healthcare LLP | Director | 03 Feb 2022 | 4 Years 9 Months | Current |
| Vijaykumar Shankarrao Moon Also directs: Enrish Natural Healthcare LLP | Director | 03 Feb 2022 | 4 Years 9 Months | Current |
| Manishkumar Gunjeshnari Mishra Also directs: Enrish Natural Healthcare LLP | Director | 07 May 2016 | 10 Years 6 Months | Current |
| Shrikant Sundar Rane | Director | 01 Dec 2016 | 9 Years 11 Months | Current |
Auditor
Enrish Pharmaceutical Private Limited is audited by A S Gadiya and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A S Gadiya and Associates | FY 2023 | 156763 |
Shareholding
The shareholding of Enrish Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Enrish Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2018 | 100169630 | Punjab and Maharashtra Co-Operative Bank Limited | ₹5 Lakh | Open | |
| 30 Mar 2017 | 100090081 | Punjab and Maharashtra Co-Operative Bank Limited | ₹3 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Enrish Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Enrish Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Enrish Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECE2708E1ZZ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Enrish Pharmaceutical Private Limited, buy the company report.
Recent activity
Enrish Pharmaceutical Private Limited has 9 board changes on record since 2016: 4 appointments and 5 cessations. The latest: Shrikant Sundar Rane ceased to be Director on 19 Jun 2025.
2 earlier events are in the company report.
Frequently asked questions
Enrish Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 May 2016 (10+ years old) and is registered under CIN U74999MH2016PTC280805.
Enrish Pharmaceutical has 4 current directors:
- Sushant Sudhir Bala - Director
- Vijaykumar Shankarrao Moon - Director
- Manishkumar Gunjeshnari Mishra - Director
- Shrikant Sundar Rane - Director
The latest financial statements of Enrish Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Enrish Pharmaceutical is 27AAECE2708E1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Enrish Pharmaceutical is U74999MH2016PTC280805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enrish Pharmaceutical was incorporated on 07 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Shrikant Sundar Rane ceased to be Director on 19 Jun 2025. Sushant Sudhir Bala ceased to be Additional Director on 29 Sep 2024. Vijaykumar Shankarrao Moon ceased to be Additional Director on 29 Sep 2024. Enrish Pharmaceutical has 9 board changes on record in total.
Yes, Enrish Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0177242).
The registered office of Enrish Pharmaceutical is at Flat No A 102 Gurudarshan Apartme Shreya Building Nandivali Dombivali East Kalyan Tahne, Thane, Maharashtra, India – 421201.
Enrish Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.

